Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11892291 | 1.00 | ALDH1A1 (0.49) | ALDH1A1NPC1RAB9ASMN1; SMN2CYP2C19 | |
| SCHEMBL14413593 | 1.00 | ALDH1A1 (0.49) | ALDH1A1NPC1RAB9ASMN1; SMN2CYP2C19 | |
| SCHEMBL9778690 | 0.82 | MAOB (0.41) | ALDH1A1NPC1RAB9ASMN1; SMN2HTR1A | |
| SCHEMBL531471 | 0.80 | MEN1 (0.50) | ALDH1A1CYP2C19MEN1KMT2ASLC6A2 | |
| SCHEMBL12944479 | 0.80 | MEN1 (0.50) | ALDH1A1CYP2C19MEN1KMT2ASLC6A2 | |
| SCHEMBL12944476 | 0.80 | MEN1 (0.50) | ALDH1A1CYP2C19MEN1KMT2ASLC6A2 | |
| SCHEMBL10450548 | 0.79 | SMN1; SMN2 (0.39) | ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10451004 | 0.79 | SLC6A2 (0.42) | ALDH1A1NPC1RAB9ASMN1; SMN2KMT2A | |
| SCHEMBL2221149 | 0.78 | TSHR (0.50) | CYP2C19MEN1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL10451078 | 0.78 | ALDH1A1 (0.38) | ALDH1A1NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119395169-A | Analysis method of peculiar smell of 1, 3-butanediol source in cosmetics | 云南贝泰妮生物科技集团股份有限公司 | 2025-02-07 | — | — | CN | claimed |
| US-20250171427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2025-05-29 | — | — | US | disclosed |
| WO-2025104230-A1 | BENZOXAZOLES AS MODULATORS OF IL-17A | SANOFI (FR) | 2025-05-22 | — | — | WO | disclosed |
| CN-119395169-A | Analysis method of peculiar smell of 1, 3-butanediol source in cosmetics | 云南贝泰妮生物科技集团股份有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-111471056-B | Macrocyclic immunomodulator | 成都先导药物开发股份有限公司 | 2021-07-02 | — | — | CN | disclosed |
| CN-111471056-A | Macrocyclic immunomodulator | 成都先导药物开发股份有限公司 | 2020-07-31 | — | — | CN | disclosed |
| US-10227423-B2 | (Ethylene, vinyl acetal) copolymers and their use in lithographic printing plate precursors | AGFA NV (BE) | 2019-03-12 | — | — | US | disclosed |
| US-20170114158-A1 | (ETHYLENE, VINYL ACETAL) COPOLYMERS AND THEIR USE IN LITHOGRAPHIC PRINTING PLATE PRECURSORS | AGFA OFFSET BV (BE) | 2017-04-27 | — | — | US | disclosed |
| EP-2152812-B1 | DEGASSING COMPOSITIONS FOR CURABLE COATINGS | TROY TECHNOLOGY CORP INC (US) | 2012-03-21 | — | — | EP | disclosed |
| EP-2152812-A1 | DEGASSING COMPOSITIONS FOR CURABLE COATINGS | Troy Technology Corporation, Inc. (US) | 2010-02-17 | — | — | EP | disclosed |
| WO-2008130538-A1 | DEGASSING COMPOSITIONS FOR CURABLE COATINGS | TROY TECHNOLOGY CORPORATION, INC. (US) | 2008-10-30 | — | — | WO | disclosed |
| US-3944674-A | Combating insects with o dimethoxymethylphenyl-N-methylcarbamate | CIBA-GEIGY AG (CH) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171427-A1 | THERAPEUTIC COMPOUNDS | IL17A, IL2, IL36G | ALDH1A1 449/4885NPC1 461/4885RAB9A 818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.